Diversified Trust’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-18,097
Closed -$58.8K 994
2024
Q4
$58.8K Hold
18,097
﹤0.01% 899
2024
Q3
$59.5K Hold
18,097
﹤0.01% 887
2024
Q2
$76.9K Buy
18,097
+4,467
+33% +$43.5K ﹤0.01% 840
2024
Q1
$201K Buy
13,630
+1,880
+16% +$28.4K 0.01% 752
2023
Q4
$113K Sell
11,750
-408
-3% -$2.82K ﹤0.01% 828
2023
Q3
$56.7K Buy
12,158
+756
+7% +$3.76K ﹤0.01% 800
2023
Q2
$61K Hold
11,402
﹤0.01% 807
2023
Q1
$81.8K Hold
11,402
﹤0.01% 791
2022
Q4
$77K Sell
11,402
-1,160
-9% -$6.36K ﹤0.01% 770
2022
Q3
$43K Hold
12,562
﹤0.01% 751
2022
Q2
$37K Buy
+12,562
New +$66K ﹤0.01% 733
2021
Q4
Sell
-10,909
Closed -$228K 878
2021
Q3
$228K Sell
10,909
-1,603
-13% -$38.6K 0.01% 676
2021
Q2
$336K Buy
12,512
+1,083
+9% +$31.7K 0.01% 510
2021
Q1
$364K Buy
11,429
+608
+6% +$14.8K 0.01% 480
2020
Q4
$247K Hold
10,821
0.01% 582
2020
Q3
$273K Sell
10,821
-165
-2% -$4.5K 0.01% 477
2020
Q2
$307K Buy
+10,986
New +$191K 0.02% 384

Other funds holding MGNX

Diversified Trust's MGNX Position: Q1 2025 in Review

Diversified Trust sold out of MacroGenics (MGNX) in Q1 2025, closing a stake of 18,097 shares — an estimated $58.8K sold.

Diversified Trust first reported a position in MGNX in Q2 2020 and held it in 17 quarters. The position peaked at $364K in Q1 2021. 128 funds tracked by Wall St. Rank hold MGNX as of Q1 2025.

  • Diversified Trust reported no remaining MacroGenics position as of Q1 2025 after selling out during the quarter.
  • Diversified Trust sold 18,097 MacroGenics shares in Q1 2025, an estimated $58.8K.
  • Diversified Trust first reported a position in MacroGenics in Q2 2020 and held it in 17 quarters.
  • Diversified Trust's MacroGenics position peaked at $364K in Q1 2021.
  • 128 funds tracked by Wall St. Rank held MacroGenics as of Q1 2025.

Based on Diversified Trust's 13F filing for Q1 2025, filed 24 Apr 2025.